Skip to content
Precision for Medicine
Contact Us
Press Release

FDA Veteran Paz Vellanki, MD, joins Precision to become one of 3 ex-FDA oncology leaders supporting clients

Read the release
false
Paz, Vellanki, MD, PhD Avatar

Paz Vellanki, MD, PhD

Former FDA oncology leader recognized for translating complex regulatory insight into actionable development strategy. Served as Associate Director in the FDA’s Division of Oncology 2, where she helped shape regulatory decisions and guide drug development across lung cancer, head and neck cancer, and rare tumors. Combines deep expertise in clinical trial design, INDs and drug applications with leadership in advancing novel endpoints, including serving as technical lead on FDA guidance for circulating tumor DNA (ctDNA) in early-stage solid tumors. 
Loading...
You've reach the end